Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roden

Showing results (441-450 of 1,010) with videos related to

Pageof 101
Sort By:
Journal of the American College of Cardiology|July 24, 2012
Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillationMarylyn D Ritchie, Shane Rowan, Gayle Kucera, et al.
The American Journal of Cardiology|August 28, 2012
Race-specific impact of atrial fibrillation risk factors in blacks and whites in the southern community cohort studyLoren Lipworth, Henry Okafor, Michael T Mumma, et al.
Diabetologia|February 25, 2005
Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanismM Artwohl, C Fürnsinn, W Waldhäusl, et al.
Molecular Immunology|October 19, 2005
Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: implications for the mechanism underlying variations in antigen presentationMatthew M Roden, Daniel R Brims, Alexander A Fedorov, et al.
Pharmacological Research|February 16, 2018
Calcium channel blockers as drug repurposing candidates for gestational diabetes: Mining large scale genomic and electronic health records data to repurpose medicationsJeffery A Goldstein, Lisa A Bastarache, Joshua C Denny, et al.
Circulation|August 1, 1983
Electrophysiologic actions of O-demethyl encainide: an active metaboliteH J Duff, A K Dawson, D M Roden, et al.
The American Journal of Cardiology|August 1, 1982
Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequencyH J Duff, D M Roden, A K Dawson, et al.
Diabetologia|December 29, 2005
Changes in hepatic glycogen cycling during a glucose load in healthy humansH Stingl, V Chandramouli, W C Schumann, et al.
Frontiers in Genetics|June 6, 2018
Identification of Central Regulators of Calcium Signaling and ECM-Receptor Interaction Genetically Associated With the Progression and Recurrence of Atrial FibrillationPetra Büttner, Laura Ueberham, M B Shoemaker, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|December 24, 2011
Modeling drug exposure data in electronic medical records: an application to warfarinMei Liu, Min Jiang, Vivian K Kawai, et al.
Pageof 101

Showing results (441-450 of 1,010) with videos related to

Sort By:
Pageof 101
Journal of the American College of Cardiology|July 24, 2012
Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillationMarylyn D Ritchie, Shane Rowan, Gayle Kucera, et al.
The American Journal of Cardiology|August 28, 2012
Race-specific impact of atrial fibrillation risk factors in blacks and whites in the southern community cohort studyLoren Lipworth, Henry Okafor, Michael T Mumma, et al.
Diabetologia|February 25, 2005
Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARgamma-independent mechanismM Artwohl, C Fürnsinn, W Waldhäusl, et al.
Molecular Immunology|October 19, 2005
Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: implications for the mechanism underlying variations in antigen presentationMatthew M Roden, Daniel R Brims, Alexander A Fedorov, et al.
Pharmacological Research|February 16, 2018
Calcium channel blockers as drug repurposing candidates for gestational diabetes: Mining large scale genomic and electronic health records data to repurpose medicationsJeffery A Goldstein, Lisa A Bastarache, Joshua C Denny, et al.
Circulation|August 1, 1983
Electrophysiologic actions of O-demethyl encainide: an active metaboliteH J Duff, A K Dawson, D M Roden, et al.
The American Journal of Cardiology|August 1, 1982
Comparison of the effects of placebo and encainide on programmed electrical stimulation and ventricular arrhythmia frequencyH J Duff, D M Roden, A K Dawson, et al.
Diabetologia|December 29, 2005
Changes in hepatic glycogen cycling during a glucose load in healthy humansH Stingl, V Chandramouli, W C Schumann, et al.
Frontiers in Genetics|June 6, 2018
Identification of Central Regulators of Calcium Signaling and ECM-Receptor Interaction Genetically Associated With the Progression and Recurrence of Atrial FibrillationPetra Büttner, Laura Ueberham, M B Shoemaker, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|December 24, 2011
Modeling drug exposure data in electronic medical records: an application to warfarinMei Liu, Min Jiang, Vivian K Kawai, et al.
Pageof 101